Product Information |
|
Registration Number |
BR-1455
|
Generic Name |
Respiratory Syncytial Virus Vaccine (Recombinant, Adjuvanted)
|
Brand Name |
Arexvy
|
Dosage Strength |
120 mcg
|
Dosage Form |
Powder for Suspension for Injection (IM)
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
-
|
Packaging |
See packaging on the reverse side.
|
Manufacturer |
GlaxoSmithKline Biologicals SA
|
Country of Origin |
Belgium
|
Trader |
|
Importer |
GlaxoSmithKline Philippines, Inc.
|
Distributor |
GlaxoSmithKline Philippines, Inc.
|
Application Type |
Monitored Release (MR)
|
Issuance Date |
22 November 2023
|
Expiry Date |
22 November 2028
|